MedPath

DM1 Heart Registry - DM1 Respiratory Registry

Completed
Conditions
Myotonic Dystrophy
Registration Number
NCT01136330
Lead Sponsor
Institut de Myologie, France
Brief Summary

Myotonic dystrophy type 1 (DM1) is the most frequent neuromuscular disease in adults. DM1 patients have an impaired prognosis (mean age of death \<60 years) due to cardiac and respiratory complications.

Our primary objective was to identify cardiac and respiratory prognostic factors in DM1.

Detailed Description

1. Patients with genetically proven DM1 who were admitted in Pitié Salpêtrière Hospital from 2000 and 2010 will be identified. These patients systematically underwent neurological, cardiac and respiratory investigations.

2. Baseline medical and genetic information will be entered in a dedicated database, including cardiac and respiratory investigations.

3. The occurence of severe cardiac and respiratory adverse events will also be collected.

4. Statistical analysis will be performed to look for correlations between baseline patient characteristics and cardiac or respiratory adverse events during follow up.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
914
Inclusion Criteria
  • DM1 mutation (>50 CTG repeats)
  • Age > 18 years
Exclusion Criteria
  • Patient refusal

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Pitié Salpêtrière Hospital

🇫🇷

Paris, Ile de France, France

© Copyright 2025. All Rights Reserved by MedPath